Estimated Bicarbonate Deficit Calculator (Explicit Distribution Factor)
Estimate a static positive bicarbonate deficit in mEq from submitted bicarbonate, an externally selected higher target, kg or lb weight, and an explicit distribution factor; not blood-gas base deficit, a sodium bicarbonate dose, product volume, or treatment output.
Content updated: View sources
QuickMedCalc is developed and maintained by an independent developer. Medical content is not independently reviewed by a physician.
Formula and medical content are based on the references listed on this page. See sources, About, and Sources and Review Process.
About
This page calculates a static positive estimated bicarbonate deficit from a submitted concentration, an externally selected higher target, body weight normalized to kilograms, and an explicit distribution factor. It displays the concentration difference and estimated mEq, without selecting a target or factor or calculating blood-gas base deficit, anion gap, pH, PCO₂, product volume, or treatment.[1, 3]
A chemistry panel commonly reports measured total CO₂ as an approximation of bicarbonate, while blood-gas HCO₃⁻ is usually calculated from pH and PCO₂. They are related but not unconditionally identical. An isolated low value can reflect metabolic acidosis or compensation for respiratory alkalosis; this page does not identify the source, confirm acidosis, or detect a mixed disorder.[2, 4]
The distribution factor is an explicit model assumption. Traditional 0.5 is not universal, and historical severe-acidosis data reported apparent spaces above 100% and even 200% of body weight. This runtime requires only a finite positive factor and imposes no physiologic maximum; accepting a numeric factor does not recommend or validate it for an individual patient. The output is not a sodium bicarbonate dose, fluid volume, rate, duration, or treatment plan.[1, 3, 12]
Formula
Interpretation
| Quantity | What it represents | Calculated here |
|---|---|---|
| Submitted bicarbonate / total CO₂ | Externally selected source concentration | Input |
| Selected target bicarbonate | External workflow’s higher target | Input |
| Explicit distribution factor | External model assumption | Input |
| Normalized body weight | Submitted kg or converted lb weight | Yes |
| Bicarbonate concentration difference | Target minus submitted value | Yes |
| Estimated bicarbonate deficit | Factor × kg × concentration difference | Yes |
| Measured total-body bicarbonate depletion | Direct physiologic measurement | No |
| Standard base excess / base deficit | Blood-gas derived acid–base quantity | No |
| pH, PCO₂, anion gap and cause | Full acid–base assessment | No |
| Sodium bicarbonate product, dose, volume, rate or monitoring | Treatment plan | No |
Target and factor are inputs, not recommendations. The estimate is not a measured body deficit or blood-gas base deficit, and the same mEq value can arise from different targets, factors, and weights. No dose, product volume, route, rate, or treatment is generated.
What this calculator computes
- Read the submitted bicarbonate concentration.
- Read an externally selected higher target.
- Normalize the submitted body weight to kilograms.
- Read the explicit distribution factor.
- Calculate target minus measured bicarbonate.
- Multiply factor × kilograms × concentration difference.
- Apply display rounding only after the full-precision calculation.
It does not read pH, PCO₂, base excess or deficit, anion gap, chloride, albumin, lactate, ketones, kidney function, ventilation, fluid status, symptoms, diagnosis, product concentration, prior treatment, or serial laboratory trends.
Input provenance and one clinical assessment
The submitted bicarbonate and weight must describe the same clinical assessment; unrelated dates, different patients, or a changing state must not be combined. The target and factor come from an applicable external workflow. Confirmation records those assumptions—it does not prove that the values are medically appropriate. Editing a number or unit clears the old result and confirmation as a software safety measure.
Chemistry total CO₂ versus blood-gas bicarbonate
Automated chemistry usually measures total CO₂ directly, with bicarbonate contributing about 95%. Blood-gas HCO₃⁻ is commonly calculated from pH and PCO₂. Specimen type, time, air exposure, handling, and method can create differences; this page does not pair, average, reconcile, or select between those sources.[2, 4]
Why a low bicarbonate value does not establish metabolic acidosis
An isolated low total CO₂ or HCO₃⁻ can reflect metabolic acidosis, but it can also reflect renal compensation for respiratory alkalosis. Mixed disorders require pH, PCO₂, anion gap, and clinical information. This calculator does not diagnose acidosis, acidemia, compensation, or a mixed disorder.[2, 3, 4]
Why the page only calculates a positive deficit
The selected target must be strictly above the submitted value. An equal target is rejected rather than shown as zero; a lower target is rejected rather than displayed as a negative deficit or “bicarbonate excess.” That is the named task and frozen runtime domain, not a treatment rule.
How the arithmetic is assembled
Pounds are first converted to kilograms. The submitted concentration is subtracted from the selected target, the difference is multiplied by the explicit factor and normalized kilograms, and the resulting unit is mEq. Internal arithmetic retains full precision; integer and two-decimal formats are applied only to the final audit display.
Why target bicarbonate is explicit
Target selection depends on information absent here, including pH, PCO₂, cause, time course, treatment objective, and serial response. The page does not prefill 24, infer a target from the submitted value, or turn a laboratory reference interval into a treatment target. It performs arithmetic only on the target supplied by the user.[3, 4]
Why the distribution factor is explicit
The factor changes the estimate linearly, so a hidden default would conceal an important model assumption. The page does not select a factor from age, sex, BMI, edema, shock, AKI, or diagnosis. Values such as 0.4, 0.5, or 0.6 are source- and task-specific background, not recommendation buttons or color-coded categories.[1]
Why 0.5 is not a universal bicarbonate space
Traditional calculations often assumed a space equal to 50% of body weight. Garella reported apparent spaces exceeding 200% in severe cases and, in 16 dogs, smaller plasma concentration increments after a fixed 2.5 mmol/kg dose when initial bicarbonate was lower. The apparent “space” reflects fluid distribution and intracellular and extracellular buffering—not a fixed anatomical compartment. Historical 0.4, 0.5, and 0.6 values are model assumptions, not universal defaults. This calculator therefore accepts an explicit positive factor without imposing a physiologic maximum; accepting a number does not recommend or validate it for an individual patient.[1]
Estimated bicarbonate deficit versus base excess or base deficit
This output uses only a bicarbonate difference, weight, and factor. Standard blood-gas base excess or base deficit is a different acid–base quantity derived from blood-gas variables and assumptions involving pH, PCO₂, bicarbonate, and hemoglobin-related buffering. The two are not interchangeable, and this page neither calculates nor interprets blood-gas base deficit.[4]
Static estimate versus sodium bicarbonate dose or product volume
An estimated mEq value is not the number of mEq that should be administered. Sodium bicarbonate injection is a hypertonic prescription product, and official labels document differing concentrations and presentations. Actual management also depends on cause, route, concentration, sodium and volume load, ventilation, ionized calcium, potassium, and serial response. This page does not calculate mL, ampules, bags, bolus, infusion, repeat dose, or “give the calculated amount.”[3, 4, 12]
Cause-specific acid–base contexts
Gastrointestinal or renal base loss, lactic acidosis and shock, DKA, AKI or CKD, toxic ingestion, and mixed acid–base disorders can produce similar bicarbonate values through different mechanisms. Evidence and risk–benefit considerations differ by cause. This page determines none of those causes and generates no treatment pathway for any of them.[3, 4, 10, 11]
Current randomized-trial evidence timeline
BICAR-ICU 2018
Among 389 ICU patients with severe metabolic acidemia, the primary composite outcome occurred in 71% of controls and 66% of the bicarbonate group, without a significant overall improvement. A prespecified AKI subgroup showed a benefit signal, while metabolic alkalosis, hypernatremia, and hypocalcemia occurred more often with bicarbonate. A subgroup signal is not a dosing rule for this calculator.[5]
BICARICU-2 2025
The trial randomized 640 patients with severe acidemia and moderate or severe AKI; 627 entered the primary analysis. Day-90 mortality was 62.1% with bicarbonate and 61.7% with control, showing no mortality benefit. Kidney replacement therapy was a secondary outcome (35% versus 50%). The intervention followed an arterial-pH target, not a weight × factor × bicarbonate-difference dose, so the secondary finding cannot generate an individual treatment conclusion here.[6]
SODa-BIC 2026
In 500 ICU patients receiving vasopressors with metabolic acidosis, the 30-day major adverse kidney event occurred in 40.2% with bicarbonate and 39.4% with placebo, with no primary-outcome or mortality benefit. The protocol targeted pH and base excess and did not validate this page's factor × weight × difference equation.[7]
These studies differ in population, design, and intervention and must not be mechanically combined. Neither a secondary outcome nor a subgroup signal is a universal rule; the evidence supports neither “always beneficial” nor “never useful.” This calculator executes none of the trial protocols.
2026 evidence syntheses
Chen et al. 2026 randomized-trial meta-analysis
This synthesis included 4 randomized trials and 1,111 patients. Mortality was inconclusive (RR 0.84, 95% CI 0.55–1.30), while kidney replacement therapy was reduced (RR 0.69, 95% CI 0.61–0.78). Those outcomes do not validate this calculator's factor × weight × bicarbonate-difference formula or select treatment for an individual.[8]
Fosset et al. 2026 individual-patient meta-analysis
The BICAR-ICU and BICAR-ICU2 individual-patient analysis included 1,016 patients. Ninety-day mortality was 58.3% with bicarbonate versus 60.6% with control (RR 0.96, 95% CI 0.86–1.07; p=0.51), and kidney replacement therapy was 34.8% versus 50.7% (RR 0.69, 95% CI 0.60–0.79). A pH ≤7.10 subgroup signal is not a calculator cutoff, treatment selector, or automatic bicarbonate recommendation; there was no significant interaction by severe AKI status or serum lactate.[9]
These syntheses and the individual trials have different eligibility, protocols, targets, and outcomes, so they must not be mechanically combined. None establishes this page's arithmetic as a dosing equation or generates a treatment recommendation.
Worked examples from the frozen implementation
Principal vector
12 measured, 24 target, 70 kg, factor 0.5: difference 12.00; raw and displayed deficit 420 mEq.
Implementation, unit, and display audit only—not a metabolic-acidosis diagnosis, blood-gas base deficit, sodium bicarbonate dose, volume, rate, or treatment plan.
Factor sensitivity
With the same 12/24/70 inputs, factor 0.4 gives 336 mEq. This does not select 0.4 or 0.5 for a patient.
Implementation, unit, and display audit only—not a metabolic-acidosis diagnosis, blood-gas base deficit, sodium bicarbonate dose, volume, rate, or treatment plan.
Target sensitivity
12 measured, 18 target, 70 kg, factor 0.5: difference 6.00 and deficit 210 mEq. The target is not recommended here.
Implementation, unit, and display audit only—not a metabolic-acidosis diagnosis, blood-gas base deficit, sodium bicarbonate dose, volume, rate, or treatment plan.
kg/lb equivalence
70 kg and 154.3235835294143 lb normalize to the same weight and produce the same raw and displayed 420 mEq.
Implementation, unit, and display audit only—not a metabolic-acidosis diagnosis, blood-gas base deficit, sodium bicarbonate dose, volume, rate, or treatment plan.
Tiny-positive result
23.99 measured, 24 target, 70 kg, factor 0.5: raw deficit is approximately 0.35 mEq; the frozen display is <1 mEq and difference 0.01.
Implementation, unit, and display audit only—not a metabolic-acidosis diagnosis, blood-gas base deficit, sodium bicarbonate dose, volume, rate, or treatment plan.
When the estimate may be unreliable
These limitations reduce reliability when the submitted source is unclear; chemistry total CO₂ and blood-gas HCO₃⁻ are mixed; value and weight come from different times; the selected target or factor does not fit the external task; severe acidemia produces an apparent space beyond this runtime's range; acid is being produced or bicarbonate lost rapidly; respiratory alkalosis, mixed disorder, or changing ventilation is present; lactic acidosis, DKA, toxin, or AKI cause is unresolved; fluid shift, edema, or unusual body composition alters assumptions; bicarbonate or dialysis has already occurred; serial values are changing; or one static value replaces a complete assessment.
What the result cannot determine
It cannot determine whether metabolic acidosis or acidemia exists; pH, PCO₂, compensation, anion gap, mixed disorder, or cause; total-body bicarbonate depletion; standard base deficit; actual distribution space; an indication for sodium bicarbonate; amount to administer; product concentration or volume; oral or IV route; bolus or infusion; rate, duration, repeat dose, sodium load, potassium, calcium, or volume effect; monitoring frequency; or dialysis, referral, admission, discharge, or any other treatment decision.
References
- Garella S, Dana CL, Chazan JA. Severity of Metabolic Acidosis as a Determinant of Bicarbonate Requirements. N Engl J Med. 1973;289:121–126. DOI 10.1056/NEJM197307192890303.
- Centor RM. Serum Total Carbon Dioxide. In: Clinical Methods. 3rd ed. Chapter 196. NCBI Bookshelf.
- Kraut JA, Madias NE. Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol. 2012;8(10):589–601. PMID 22945490. DOI 10.1038/nrneph.2012.186.
- Jung B, et al. Diagnosis and management of metabolic acidosis: guidelines from a French expert panel. Ann Intensive Care. 2019;9:92. PMID 31418093. PMCID PMC6695455. DOI 10.1186/s13613-019-0563-2.
- Jaber S, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU). Lancet. 2018;392:31–40. PMID 29910040. DOI 10.1016/S0140-6736(18)31080-8.
- Jung B, et al. Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury: The BICARICU-2 Randomized Clinical Trial. JAMA. 2025;334(22):2000–2010. PMID 41159812. DOI 10.1001/jama.2025.20231.
- SODa-BIC Investigators. Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock. N Engl J Med. Published online June 12, 2026. PMID 42283370. DOI 10.1056/NEJMoa2600526.
- Chen JJ, et al. Sodium Bicarbonate for Acute Metabolic Acidosis in Critically Ill Adults: A Meta-Analysis of Randomized Clinical Trials. Crit Care Med. 2026. PMID 42171427. DOI 10.1097/CCM.0000000000007179.
- Fosset M, et al. Sodium bicarbonate therapy in severe metabolic acidemia: an individual patient data meta-analysis of the BICAR-ICU and BICAR-ICU2 trials. Crit Care. 2026 Jul 19. PMID 42472834. DOI 10.1186/s13054-026-06206-3.
- Evans L, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Med. 2021;47:1181–1247. PMID 34599691. DOI 10.1007/s00134-021-06506-y.
- Umpierrez GE, et al. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care. 2024;47:1257–1275. PMID 39052901. PMCID PMC11272983. DOI 10.2337/dci24-0032. A companion publication appeared in Diabetologia (PMID 38907161; PMCID PMC11343900; DOI 10.1007/s00125-024-06183-8).
- DailyMed. Sodium Bicarbonate Injection, USP, 8.4% (84 mg/mL), prescription drug label. Set ID ccf8e08c-2efb-4a92-a4c2-042dba2eacfa. Label updated August 13, 2025. The label states that 84 mg supplies 1 mEq each of sodium and bicarbonate.
FAQ
Estimated deficit in mEq = explicit distribution factor × normalized weight in kg × (externally selected target − submitted bicarbonate). The calculator implements only a positive-deficit domain, so target must be higher than measured. The result is a static estimate, not a dose.
Sources: [1]
The factor changes the result linearly, so hiding a default would conceal a major model assumption. The page does not select it from demographic or clinical variables.
Sources: [1]
No. Historical severe-acidemia observations found much larger apparent distribution spaces. This calculator accepts an explicit positive factor without imposing a physiologic maximum; accepting a number does not recommend or validate it for an individual patient.
Sources: [1]
No. This page multiplies a submitted bicarbonate difference by weight and factor. Blood-gas base excess or deficit is a different acid–base quantity derived from blood-gas variables and buffering assumptions.
Sources: [4]
They do not establish a simple universal benefit. BICAR-ICU found no significant overall primary benefit but an AKI subgroup signal; BICARICU-2 found no mortality benefit but lower kidney replacement therapy as a secondary outcome; SODa-BIC found no 30-day major-adverse-kidney-event benefit. The 2026 randomized-trial meta-analysis included 4 RCTs and 1,111 patients, with inconclusive mortality (RR 0.84, 95% CI 0.55–1.30) but reduced kidney replacement therapy (RR 0.69, 95% CI 0.61–0.78). The 2026 individual-patient analysis included 1,016 patients, found 90-day mortality 58.3% versus 60.6% (RR 0.96, 95% CI 0.86–1.07; p=0.51) and kidney replacement therapy 34.8% versus 50.7% (RR 0.69, 95% CI 0.60–0.79); its pH ≤7.10 subgroup signal is not a cutoff or treatment selector. None used or validated this calculator’s factor × weight × difference formula.
Related Calculators
Anion Gap
Calculate serum anion gap from sodium, chloride, and bicarbonate or total CO₂ using the standard formula without potassium.
Adjusted AG
Calculate a signed sodium-only Figge 2.5 albumin-adjusted anion gap from same-specimen or paired chemistry and albumin in g/dL or g/L, with no universal interval, diagnosis, delta ratio, or treatment output.
Urine Anion Gap
Calculate the one-decimal signed urine anion gap from sodium, potassium, and chloride in the same urine specimen using mmol/L or mEq/L, without treating UAG as direct urine ammonium or a universal positive/negative diagnosis.
Disclaimer
Educational and informational reference only. Not intended to replace professional medical advice, diagnosis, treatment, or independent verification.